UK Research Identifies Cellular Anomalies Offering Potential New Therapeutic Targets for Preeclampsia

Summary

Researchers have discovered distinct cellular activity in mothers and infants affected by preeclampsia, offering a roadmap for targeted drug development for a condition that affects up to 4% of global pregnancies and currently lacks a cure beyond delivery.

The finding updates the evidence base in Maternal & Newborn and Therapeutics and is worth reading against prior studies on the same endpoint. Clinical-stage and evidence-dependent operators in the lane feel these prints first.

Sources

• OVUM Primary source